The earnings call presented a mixed picture. While there was notable growth in revenue and net income, the company faced significant challenges with declining net new business awards, elevated cancellations, and a decrease in EBITDA margin. The guidance for 2025 reflects these challenges, with potential for only modest growth.
Company Guidance
During the Medpace Holdings, Inc. first quarter 2025 earnings call, the company provided guidance for the year, expecting total revenue to range from $2.14 billion to $2.24 billion, reflecting growth of 1.5% to 6.2% compared to 2024. The EBITDA is anticipated to be between $462 million and $492 million, representing a potential decline of 3.8% to growth of 2.5% from the previous year's EBITDA of $480.2 million. Net income is forecasted to be in the range of $378 million to $402 million, with an effective tax rate of 15.5% to 16.5%. Earnings per diluted share are projected to be between $12.26 and $13.04. The guidance assumes foreign exchange rates as of March 31, 2025, with no additional share repurchases included. The company's focus on the backlog is evident, with $1.61 billion expected to convert to revenue over the next twelve months, and they aim to achieve book-to-bill ratios above 1.15 in the latter half of the year, contingent on moderating cancellations and an improved business climate.
Revenue Growth
Revenue for the first quarter of 2025 was $558.6 million, marking a year-over-year increase of 9.3%.
Net Income Increase
Net income for the first quarter of 2025 was $114.6 million, an 11.7% increase compared to the prior year period.
Strong Cash Flow
The company generated $125.8 million in cash flow from operating activities during the first quarter.
---
Medpace Holdings (MEDP) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MEDP Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 21, 2025
$288.99
―
―
Feb 10, 2025
$354.51
$327.86
-7.52%
Oct 21, 2024
$352.92
$326.54
-7.47%
Jul 22, 2024
$437.18
$357.30
-18.27%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Medpace Holdings (MEDP) report earnings?
Medpace Holdings (MEDP) is schdueled to report earning on Jul 28, 2025, TBA Not Confirmed.
What is Medpace Holdings (MEDP) earnings time?
Medpace Holdings (MEDP) earnings time is at Jul 28, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.